Krystal Biotech Files 8-K: Corporate Details Updated
Ticker: KRYS · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1711279
| Field | Detail |
|---|---|
| Company | Krystal Biotech, Inc. (KRYS) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, filing
TL;DR
Krystal Biotech filed an 8-K on 10/22/25 updating corporate address and contact info.
AI Summary
Krystal Biotech, Inc. filed an 8-K on October 22, 2025, reporting an event under 'Other Events'. The filing details the company's principal executive offices located at 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania, 15203, and its telephone number (412) 586-5830. The company is incorporated in Delaware and operates in the Biological Products sector.
Why It Matters
This filing provides updated corporate information for Krystal Biotech, Inc., which is important for investors and stakeholders to ensure they have the most current contact and location details for the company.
Risk Assessment
Risk Level: low — The filing is a routine corporate update and does not contain material non-public information that would typically impact stock price.
Key Players & Entities
- Krystal Biotech, Inc. (company) — Registrant
- October 22, 2025 (date) — Date of Report
- 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania, 15203 (location) — Principal executive offices
- (412) 586-5830 (phone_number) — Registrant's telephone number
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing by Krystal Biotech, Inc.?
The primary purpose of this 8-K filing is to report an event under 'Other Events', specifically updating corporate information such as the principal executive offices and contact details.
When was this 8-K report filed by Krystal Biotech, Inc.?
This 8-K report was filed on October 22, 2025.
Where are Krystal Biotech, Inc.'s principal executive offices located?
Krystal Biotech, Inc.'s principal executive offices are located at 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania, 15203.
What is the telephone number for Krystal Biotech, Inc.?
The telephone number for Krystal Biotech, Inc. is (412) 586-5830.
In which state is Krystal Biotech, Inc. incorporated?
Krystal Biotech, Inc. is incorporated in Delaware.
Filing Stats: 429 words · 2 min read · ~1 pages · Grade level 12.3 · Accepted 2025-10-22 08:01:41
Filing Documents
- krys-20251022.htm (8-K) — 29KB
- 0001711279-25-000082.txt ( ) — 133KB
- krys-20251022.xsd (EX-101.SCH) — 2KB
- krys-20251022_lab.xml (EX-101.LAB) — 20KB
- krys-20251022_pre.xml (EX-101.PRE) — 11KB
- krys-20251022_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events Krystal Biotech, Inc. today reported that, effective as of October 22, 2025, its wholly owned subsidiary, Krystal Biotech Japan KK, commenced the commercial launch of VYJUVEK (beremagene geperpavec) in Japan for the treatment of dystrophic epidermolysis bullosa following its inclusion on Japan's National Health Insurance (NHI) Drug Price List on the same date. VYJUVEK has been listed on the NHI Drug Price List at a price of 2,955,232.7 yen per unit. This Current Report on Form 8-K is being furnished for informational purposes only.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 22, 2025 KRYSTAL BIOTECH, INC. By: /s/ Krish S. Krishnan Name: Krish S. Krishnan Title: Chairman and Chief Executive Officer